BIOCARTIS

In News

Press Release Biocartis NV: Biocartis and Discovery Life - GlobeNewswire

GlobeNewswire - Jul 07, 2026

Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test - Clinical Lab Products

Clinical Lab Products - Apr 17, 2026

Biocartis and Mayo Clinic to Collaborate on Rapid Breast Cancer Diagnostic Test - Femtech Insider

Femtech Insider - Jan 13, 2026

Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer - GlobeNewswire

GlobeNewswire - Jun 09, 2026

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC - OncLive

OncLive - Sep 15, 2025

Biocartis Introduces Influenza-Respiratory Virus Panel on Idylla Platform - respiratory-therapy.com

respiratory-therapy.com - Nov 09, 2023

Press Release Biocartis NV: Biocartis to Collaborate with - GlobeNewswire

GlobeNewswire - Mar 24, 2026

Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News

Oncology Nursing News - Apr 04, 2025

Biocartis grabs lab space, staff from Johnson & Johnson to fuel U.S. expansion - Fierce Biotech

Fierce Biotech - Mar 02, 2018

Biocartis, MRC Technology to Develop Liquid Biopsy Test for Breast Cancer - Inside Precision Medicine

Inside Precision Medicine - Jun 07, 2017

Biocartis shareholders see their investment go up in smoke with planned stock market exit - marketscreener.com

marketscreener.com - Sep 26, 2023

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access - PR Newswire

PR Newswire - Sep 13, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment